Angiosarcoma
📧 Sign up to get email alerts when something new happens for Angiosarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma [Phase 2]
Phase 2 trial evaluating doxorubicin with upfront dexrazoxane for advanced or metastatic soft tissue sarcoma has completed enrollment with r…
-
CLINICAL_TRIALS trial_result · 2022-08-19Clinical Trial Update: Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma [Phase 2]
Phase 2 trial of pazopanib hydrochloride in advanced angiosarcoma has completed and results were posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-03-22Clinical Trial Update: Evaluation of Votrient in Angiosarcoma [Phase 2]
Phase 2 trial evaluating Votrient (pazopanib) in angiosarcoma; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2021-03-18Clinical Trial Update: A Study of Axitinib in Patients With Advanced Angiosarcoma and Other Soft Tissue Sarcomas [Phase 2]
Phase 2 trial update for axitinib in advanced angiosarcoma and other soft tissue sarcomas has completed.
-
CLINICAL_TRIALS trial_result · 2020-07-29Clinical Trial Update: Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma [Phase 2]
Phase 2 trial evaluating daily oral regorafenib in chemotherapy-refractory, metastatic, and locally advanced angiosarcoma; study completed w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-05-12Clinical Trial Update: Trial of TRC105 and Pazopanib Versus Pazopanib Alone in Patients With Advanced Angiosarcoma [Phase 3]
Phase 3 trial comparing TRC105 plus pazopanib versus pazopanib alone in advanced angiosarcoma has completed with results posted.
-
CLINICAL_TRIALS research · 2018-07-11Clinical Trial Update: Paclitaxel-Avelumab for Angiosarcoma [Phase 2]
This document reports a Phase 2 clinical trial investigating the combination of paclitaxel and avelumab for metastatic angiosarcoma.
-
CLINICAL_TRIALS trial_result · 2018-06-25Clinical Trial Update: Bevacizumab in Treating Patients With Angiosarcoma [Phase 2]
Phase 2 trial evaluating bevacizumab for angiosarcoma has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-03-26Clinical Trial Update: Paclitaxel + Bevacizumab (Avastin) for the Treatment of Metastatic or Unresectable Angiosarcoma [Phase 2]
A Phase 2 trial of paclitaxel plus bevacizumab for metastatic or unresectable angiosarcoma has been terminated, with results posted in March…
-
CLINICAL_TRIALS trial_result · 2017-05-12Clinical Trial Update: Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma [Phase 2]
Phase 2 clinical trial update for romidepsin (depsipeptide) in patients with metastatic or unresectable soft tissue sarcoma, with results po…
-
CLINICAL_TRIALS trial_result · 2016-08-30Clinical Trial Update: Paclitaxel in Treating Patients With Locally Advanced or Metastatic Soft Tissue Angiosarcoma or Lymphangiosarcoma That Cannot Be Removed By Surgery [Phase 2]
Phase 2 trial update evaluating paclitaxel for locally advanced or metastatic soft tissue angiosarcoma or lymphangiosarcoma that cannot be r…
-
CLINICAL_TRIALS trial_result · 2016-07-22Clinical Trial Update: Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma [Phase 1, Phase 2]
Phase 1/Phase 2 trial evaluating vismodegib with RO4929097 targeting Hedgehog and Notch pathways in various advanced/metastatic soft tissue …
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma [Phase 1]
This Phase 1 trial evaluated the combination of cixutumumab and doxorubicin in patients with unresectable, locally advanced, or metastatic s…
-
CLINICAL_TRIALS research · 2016-05-17Clinical Trial Update: Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas
A completed clinical trial update studying gene expression in tissue samples from children and adolescents with soft tissue sarcomas to bett…
-
CLINICAL_TRIALS research · 2016-04-11Clinical Trial Update: Dose-Finding of Propranolol in Combination With Metronomic Fixed Oral Cyclophosphamide Based on Bivariate Efficacy-tolerability Outcome in Patients With Locally Advanced or Metastatic Angiosarcoma: A Collaborative and Innovative Phase I-II Sequential Trial by the French Sarcoma Group (GSF/GETO) [Phase 1, Phase 2]
Clinical trial update outlining dose-finding in a sequential Phase I–II study of propranolol with metronomic fixed oral cyclophosphamide for…
-
CLINICAL_TRIALS trial_result · 2016-01-25Clinical Trial Update: Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes [Phase 2]
A Phase 2 trial evaluated the combination of gemcitabine, docetaxel, and bevacizumab in selected sarcoma subtypes, including leiomyosarcoma …
-
CLINICAL_TRIALS trial_result · 2015-07-02Clinical Trial Update: Trebananib in Treating Patients With Advanced Angiosarcoma That Cannot Be Removed by Surgery [Phase 2]
This Phase 2 trial evaluated trebananib in patients with advanced angiosarcoma unsuitable for surgical resection; the study has completed an…
-
CLINICAL_TRIALS trial_result · 2014-01-20Clinical Trial Update: Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma [Phase 2]
Phase 2 clinical trial evaluating sorafenib for metastatic, locally advanced, or recurrent sarcoma has completed and posted results in 2014.
-
CLINICAL_TRIALS research · 2009-12-24Clinical Trial Update: Sorafenib in Treating Patients With Angiosarcoma That is Locally Advanced, Metastatic, or Unable to Be Removed by Surgery [Phase 2]
Phase 2 clinical trial update examining sorafenib for angiosarcoma that is locally advanced, metastatic, or unresectable. Sponsor: Centre Os…